Hutch News

Hutch News

Stories tagged 'Other Diseases'

Gene editing holds promise for shrinking HIV ‘reservoir’

Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals

April 25, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch study shows gene editing holds promise for shrinking HIV "reservoir" — a key step toward driving the virus into remission without the need for antivirals.

View story >


25 powerful years of HIV research

Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission

Feb. 26, 2018 | By Sabrina Richards / Fred Hutch News Service

For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 4, 2018

Increasing access to stem cell transplants; improving survival, QOL for those with scleroderma; biostatistician named chair-elect of AAAS Section on Statistics.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 30, 2017

The Parker Institute for Cancer Immunotherapy announced that Dr. Phil Greenberg, head of the Program in Immunology at the Hutch, has joined its team of more than 300 scientists from the academic, nonprofit, biotech and pharma sectors.

View story >


Insights from infants could inform HIV vaccine design

Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV

Nov. 27, 2017 | By Sabrina Richards / Fred Hutch News Service

Infant immune responses to HIV could provide clues to help build protective or therapeutic HIV vaccines.

View story >


First systematic study of infections after CAR T-cell therapy

“Benchmark” research could help reduce complications of emerging immunotherapy

Nov. 6, 2017 | by Susan Keown / Fred Hutch News Service

The first detailed study of infections after CAR T-cell therapy could help researchers improve the safety of this emerging type of genetically engineered cell therapy for cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.